PRKCD and systemic sclerosis: Figure 6a displays expression levels in rottlerin treated normal and SSc fibroblasts whereas Figure 6b displays expression levels in siRNA treated fibroblasts and Figure 6c displays expression of these genes in fibroblasts treated with the inhibitory PKC-δ peptide.